Avai Bio AVAI
OTC AVAI
$0.10 -0.01 (-9.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Avai Bio (AVAI) Research & Development (2025 - 2026)

Updated

Avai Bio (AVAI) reported Research & Development of -$8,804 for fiscal Q4 2026 (quarter ended Mar 31, 2026).

Analysis

Avai Bio (AVAI) Research & Development (2025 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Avai Bio posted Research & Development of $15,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Palo Alto Networks 289.26 Bn 274.33 Bn 2.30 Bn 779.00 Mn
2 CrowdStrike Holdings 243.64 Bn 224.08 Bn 1.10 Bn 444.20 Mn
3 Fortinet 126.90 Bn 112.83 Bn 1.64 Bn 225.00 Mn
4 Snowflake 110.61 Bn 97.93 Bn 1.04 Bn 567.48 Mn
5 Datadog 92.52 Bn 74.16 Bn 881.34 Mn 477.97 Mn
6 Zscaler 38.77 Bn 24.89 Bn - -
7 Axon Enterprise 33.68 Bn 28.20 Bn 546.45 Mn 208.69 Mn
8 Okta 33.65 Bn 23.75 Bn 641.00 Mn 163.00 Mn
9 MongoDB 29.18 Bn 19.65 Bn 569.77 Mn 213.87 Mn
10 Avai Bio 15.39 Mn 15.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -8,804.00
Sep 30, 2025 23,804.00
API Access

Avai Bio Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=AVAI&period=max&api_key=YOUR_API_KEY